(571) 447-5500

Since COVID-19 was first identified, the FDA regulated industries have been trying to navigate the unique impacts that it has had on the health of our nation, our economy, as well as the global supply chain. We are all learning how to work in new ways as we strive to stop the spread of this virus and protect our families, employees, neighbors and communities.

While the FDA has temporarily amended or suspended certain provisions and is implementing enforcement discretion, the agency is clear that it fully expects firms to continue to operate in a compliant manner to ensure the ongoing safety of the products it regulates.

This has left many firms challenged with how to continue operations given reduced workforces, possible limitations in supply chains and of course, social distancing.

To that end, EAS is announcing a webinar series covering various aspects of compliance in the era of COVID-19. In this issue of EASeNews you’ll see just the start of our e-learning initiatives, including:

We are in the process of scheduling additional webinars and look forward to providing you with the most up to date regulatory information and guidance available. You may also wish to refer to the EAS website, where we have added a new column on our homepage with summaries of various FDA related COVID-19 information.

Please let us know how EAS can support you and know that we remain committed to providing you with the most comprehensive regulatory support available, both now and in the future.

Be well and stay safe.

Dean R. Cirotta Signature

Dean R. Cirotta
EAS Consulting Group

Posted in COVID-19, Extra Article and tagged .